Aug 5, 2021| JD Health
JD Health May Issue Nucleic Acid Testing Results in Two Hours
by Hui Zhang
JD Health announced to upgrade nucleic acid testing services on August 3 by cooperation with testing institutions, with results issued in as fast as 2 hours.
The service update follows a recent spike of COVID-19 cases in Nanjing and Zhangjiajie. JD’s users can simply type in the keywords “核酸检测” (nucleic acid test) to place an order. Consumers can book the testing time online, and bring their ID cards to offline institutions to receive the service and the results can be issued within 24 hours. So far, the service is available in 45 cities across China.
Meanwhile, users can also access the door-to-door sample collection service within JD’s app, making it convenient for them to complete the test without leaving home. So far, the service is available in cities including Beijing, Zhengzhou, Qingdao, Jinan, Hangzhou, Chongqing and Kunming. The results will be issued within 1-2 days.
Previously, JD Health also launched a dynamic information platform within JD’s app to release vaccine-related news from all over the country, including the latest news on the development and availability of the COVID-19 vaccine.
Negative nucleic acid test results within 48 hours are required for entrance into many places in China.
Nov 25, 2021| JD Health
JD Health Launches Online Psychiatric Service with Wuxi Partner
by Vivian Yang
JD Health and Wuxi Mental Health Center of Jiangsu province jointly announced the launch of online psychiatric treatment service on JD Health’s App on November 19.
The collaboration aims to improve the diagnosis and treatment of psychiatric diseases through online follow-up consultations, remote consultations, online training, online expert team consultations, and more, by combining JD Health’s telemedicine and the Center’s professional expertise.
Nearly 40 doctors from the Center form the platform’s first expert group. On the day of the launch, Wang Guoqiang, the Center’s director of clinical psychology, led a livestream session to teach people how to care for their mental health in the face of long-term COVID conditions. Beginning on November 19, the two parties conducted a week-long free online consultation campaign to assist the public need.
Unlike other diseases, the treatment of psychiatric ones is less reliant on imaging and laboratory examinations and more reliant on doctors’ consultation and assessment of patients’ conditions, who typically require ongoing psychological counseling and treatment, which gives online treatment a big room to grow. It is especially helpful in a pandemic situation to reduce cross-infection.
JD Health’s “1+1” model, which entails adding JD Health’s internet hospital to each offline hospital’s existing self-built internet hospital, can significantly improve physical hospitals’ ability to upgrade their telemedicine services.
Wuxi Mental Health Center’s internet hospital on JD Health’s App
According to Xue Meihua, director of Wuxi Mental Health Center, the dual operation mode of self-built and co-built internet hospitals with JD Health is mutually beneficial to both sides, and it can help maximize the value of internet hospitals in order to provide more high-quality and convenient medical and health services to patients.
Jin Fangyi, general manager of JD Health’s department of specialized internet hospital, stated that the two parties will continue to explore new paths for the diagnosis and treatment of mental and psychological diseases through telemedicine scenarios, bringing together more diverse and premier medical resources and improving online and offline integration for better psychiatric-psychological diagnosis and treatment services.
Mental health issues have grown in prominence as a social issue in China. According to the Institute of Psychology of the Chinese Academy of Sciences’ “China National Mental Health Development Report (2019-2020),” the detection rate of depression among adolescents in 2020 is 24.6 percent, with the most notable anxiety felt in the age group of 18 to 24, indicating a diagnosis increase in psychological disorders among young people. Furthermore, the survey included in the report revealed a significant decline in people’s mental health compared to ten years ago, with as many as 45.9 percent of respondents claiming that their mental health has deteriorated.
Aug 26, 2021| JD Health
JD Health H1 FY21 Earnings: Users Growth, Cold Chain Medicine Delivery and Digital Transformation
by Vivian Yang and Hui Zhang
JD Health reported its H1 FY21 earnings results on August 25. Highlights include:
- Revenue growth of 55.4% year-on-year to RMB 13.64 billion
- Annual active users on the platform reached 109 million, an increase of more than 18.8 million new users for the 12 months ended June 30, 2021
- Retail pharmacy businesses have covered 400,000 SKUs
- Over 130,000 doctors are practicing either full-time or part-time on the platform, with average daily online consultations exceeding 160,000
JD Health is positioned to create a technology-driven platform that centers on the supply chain of pharmaceutical and healthcare products and is strengthened by healthcare services, encompassing a user’s full life span for all healthcare needs. In the first half of the year, JD Health has expanded its technological capabilities to support the digital transformation of real-economy enterprises in China, in particular SMEs and organizations from the grassroots and rural areas.
“We are constantly strengthening our capabilities on ‘retail pharmacy + healthcare services,’ and will continue to make progress on opening them up to society,” said Lijun Xin, CEO of JD Health. “On the one hand, we aim at supporting the digital transformation process of enterprises across the industrial value chain. On the other hand, we have increased investment on social value creation by providing digital technologies to support health services development in grassroots level and rural areas, promoting inclusive healthcare services to every user and making more contributions to the high-quality growth of China’s real economy.”
With the resurgence of COVID cases in China since early 2021, JD Health has been upgrading its online platform and offline service network, with experiences accrued last year, to provide bookings and home services for the public to conduct nucleic acid tests and vaccinations.
When Henan province was inundated by severe floods in mid-July this year, the company responded swiftly in the relief work including launching 24/7 free online medical consultation services, donating disinfection and anti-pandemic materials, dispatching medical rescue teams on site, and providing supportive measures for local partners and SMEs.
In this March, JD Health established its Rare Diseases Care Center to build a one-stop solution platform for patients with rare diseases, helping them to tackle difficulties in accessing medical treatment, medicine, insurance and charity support.
Health Products Distribution
JD Health’s self-operated business grew by 52.9% reaching RMB 11.8 billion during the reporting period. It is currently operating 17 medicine warehouses and over 350 non-medicine warehouses. Leveraging JD Logistics nationwide infrastructure, it has established cold-chain delivery capabilities in about 100 cities across China. To further expand people’s access to new special medicines, JD Health also opened a number of next-to-hospital and DTP drug stores offline.
During the reporting period, JD Health continued to deepen cooperation with leading pharmaceutical companies including UBC China, Sanofi China, Novartis, Guilong Pharmaceutical and more, with the goal to improve medicine circulation in China through a highly-efficient, digitalized and intelligent medicine supply chain.
Meanwhile, the company is leveraging the Customer-to-Manufacturer (C2M) model to help more producers create customized products for targeted users, further promoting the upgrade of consumption and the industrial value chain. A number of customized products under JD Health’s C2M model have been introduced to the market and have gained popularity in H1 this year, including Chinese-New-Year themed masks, masks with essence oil, scented disinfectant gel, antibacterial hand cream and more.
JD Health has also stepped up efforts on its omni-channel deployment and pharmacy alliance model. In the first half of the year, JD’s fast drug delivery services have covered over 300cities across the country, providing 24/7 service for customers. Meanwhile, it extended smart supply chain capabilities to SMEs to improve cost and operating efficiency, supporting over 500 drug stores under the JD Pharmacy Alliance across the country.
JD Health continued to improve its online consultation services by introducing more specialized medical centers online. As of June 30, the number of specialized medical centers rose to 24, with the number of both internal and external physicians and specialists exceeding 130,000. The average daily online consultation volume in the first half of the year continued to skyrocket during the report time, surpassing 160,000.
In 2020, JD Health launched the “family doctor” telemedicine service program to provide timely, consistent and comprehensive primary healthcare support for Chinese families. During the report period, the number of active users of JD’s “family doctor” services accounted for 87% of the total number of service users. The average monthly user growth rate so far reached 220%.
JD Health also continued to integrate online and offline services by providing users with services such as physical examination, medical cosmetology, stomatology, nucleic acid testing, vaccines and so on.
JD Health has been constantly offering intelligent solutions for offline institutions such as local governments and offline hospitals among others to contribute in optimizing the reasonable allocation of medical services and resources. For example, JD Health launched its first Internet hospital for Traditional Chinese Medicine (TCM) in cooperation with the First Affiliated Hospital of Henan University of Chinese Medicine.
Leveraging JD’s big data, AI, 5G among other technologies, JD Health is also helping to promote the construction of “Health City” projects in several cities including Beihai in Guangxi, Taicang in Jiangsu and Hebi in Henan. Meanwhile, JD Health also provides a one-stop omni-channel digital intelligence solution for offline retail pharmacies, helping to connect industry to commerce, commerce to terminal pharmacies, and pharmacies to users, and further promoting the transformation and upgrading of traditional offline retail pharmacies.
Stay up to date on the latest news from JD.com
Enter your email address to subscribe to this blog and receive notifications of new posts by email.